|
1-(1Z-hexadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine |
|
CHEBI:133636 |
|
1-(1Z-hexadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine |
|
A 1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups are specified as (1Z)-hexadecenyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
CHEBI:89987
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C46H80NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-26-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-21-19-17-15-13-11-9-7-2/h8,10,14,16,20,22,24-25,27,29,33,35,38,41,45H,6-7,9,11-13,15,17-19,21,23,26,28,30-32,34,36-37,39-40,42-44H2,1-5H3/b10-8-,16-14-,22-20-,25-24-,29-27-,35-33-,41-38-/t45-/m1/s1 |
QICWUUGBNFIZAZ-KMPUTSBYSA-N |
[C@@H](OC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)(CO/C=C\CCCCCCCCCCCCCC)COP(OCC[N+](C)(C)C)(=O)[O-] |
|
Outgoing
|
1-(1Z-hexadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
(CHEBI:133636)
is a
1-(Z)-alk-1-enyl-2-acyl-sn-glycero-3-phosphocholine
(CHEBI:77286)
1-(1Z-hexadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
(CHEBI:133636)
is a
phosphatidylcholine P-38:6
(CHEBI:132590)
|
|
(2R)-2-{[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy}-3-{[(1Z)-hexadec-1-en-1-yl]oxy}propyl 2-(trimethylazaniumyl)ethyl phosphate
|
1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPC
|
ChEBI
|
1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPC (P-16:0/22:6)
|
ChEBI
|
1-(1-Enyl-palmitoyl)-2-docosahexaenoyl-sn-glycero-3-phosphocholine
|
HMDB
|
1-[(1Z)-hexadecenyl]-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine
|
ChEBI
|
GPC(P-16:0/22:6)
|
ChEBI
|
PC(16:0p/22:6)
|
ChEBI
|
PC(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
|
ChEBI
|
PC(P-16:0/22:6)
|
ChEBI
|
24023812
|
PubMed citation
|
Europe PMC
|
|